Skip to main content
SpringerLink
Log in

Tachykarde Rhythmusstörungen

  • Chapter
Therapie innerer Krankheiten

  • 200 Accesses

Zusammenfassung

Die Therapie tachykarder Rhythmusstörungen wurde in den vergangen 10 Jahren revolutioniert. Der Stellenwert der medikamentösen antiarrhythmischen Therapie hat stark abgenommen, nachdem die CAST-Studie (Cardiac Arrhythmia Suppression Trial Investigators 1989) eine Übersterblichkeit von Patienten mit ventrikulären Arrhythmien nach Myokardinfarkt unter Klasse-I-Antiarrhythmika gezeigt hatte. Dank der rasanten technologischen Entwicklung sind maligne ventrikuläre Arrhythmien zur Domäne des implantierbaren Defibrillators geworden (The Antiarrhythmics versus Implantable Defibrillators [AVID] Investigators 1997). Regelmäßige supraventrikuläre Tachykardien können mit hoher Erfolgsrate durch die Radiofrequenz-Katheterablation kurativ behandelt werden. Die Therapie des weit verbreiteten Vorhofflimmerns bleibt im Wesentlichen eine medikamentöse, wobei erste interventionelle Verfahren für die Zukunft auf kurative Ansätze hoffen lassen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833

    Google Scholar 

  • Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM (2004) Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150

    Article  CAS  PubMed  Google Scholar 

  • Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341:1882–1890

    Article  CAS  PubMed  Google Scholar 

  • Cairns JA et al. (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations:CAMIAT. Lancet 349:675

    CAS  PubMed  Google Scholar 

  • Capucci A et al. (1994) Conversion of recent onset atrial fibrillation to sinus rhythm by a single oral loading dose of propafenone or flecainide. Am J Cardiol 74:503

    Article  CAS  PubMed  Google Scholar 

  • Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406

    Google Scholar 

  • Dorian P, Cass D, Schwartz B et al. (2002) Amiodarone as compared to with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 346:884–890

    Article  CAS  PubMed  Google Scholar 

  • Fetsch T, Breithardt G, Engberding R et al. (2001) Prevention of atrial fibrillation after cardioversion-results from the PAFAC trial. Circulation 104(Suppl II): 699 (Abstract)

    Google Scholar 

  • Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG, on behalf of the Stroke Prevention in Atrial Fibrillation Investigators (1992) Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 20:527

    CAS  PubMed  Google Scholar 

  • Fuster V et al. (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. Circulation 104:2118–2150

    CAS  PubMed  Google Scholar 

  • Haissaguerre M, Jais P, Shah D et al. (2000) Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 101:1409–1417

    CAS  PubMed  Google Scholar 

  • Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP (1981) Amiodarone — clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 305:539

    CAS  PubMed  Google Scholar 

  • Hohnloser SH, Kuck KH, Lilienthal J (2000) Rhythm or rate control in atrial fibrillation — Pharmacological Intervention in Atrial Fibrillation (PIAF):a randomized trial. Lancet 356:1789–1794

    Article  CAS  PubMed  Google Scholar 

  • Huikuri HV, Castellanos A, Myerburg RJ (2001) Sudden death due to cardiac arrhythmias. N Engl J Med 345:1473–1482

    Article  CAS  PubMed  Google Scholar 

  • Jackman WM, Wang X, Friday KJ, Roman CA et al. (1991) Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 324: 1605

    CAS  PubMed  Google Scholar 

  • Jackman WM, Beckman KJ, McClelland JH et al. (1992) Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow pathway conduction. N Engl J Med 327:313

    CAS  PubMed  Google Scholar 

  • Julian DG et al. (1997) Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349:667

    CAS  PubMed  Google Scholar 

  • Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH (2004) Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158

    Article  CAS  PubMed  Google Scholar 

  • Klein AL, Grimm RA, Murray RD et al. (2001) Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 344:1411–1420

    CAS  PubMed  Google Scholar 

  • Lüderitz B (1998) Therapie der Herzrhythmusstörungen, 5. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop T, von Leitner ER, Andresen D, Meyer J (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 53:902

    Article  CAS  PubMed  Google Scholar 

  • MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353: 2001–2007

    Google Scholar 

  • Morady F, Sauve MJ, Malone P, Shen EN, Schwartz AB, Bhzandari A, Keung E, Sung RJ, Scheinman MM (1983) Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am J Cardiol 52:975

    Article  CAS  PubMed  Google Scholar 

  • Moss AJ et al. (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933

    Article  CAS  PubMed  Google Scholar 

  • Moss AJ et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    PubMed  Google Scholar 

  • Multicenter Postinfarction Research Group (1983) Risk stratification and survival after myocardial infarction. N Engl J Med 309:331

    Google Scholar 

  • Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet I:175

    Google Scholar 

  • Reithmann C, Hoffmann E, Spitzlberger G et al. (2000) Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. Eur Heart J 21:565–572

    Article  CAS  PubMed  Google Scholar 

  • Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013–1022

    Article  CAS  PubMed  Google Scholar 

  • SPAF II:The Stroke Prevention in Atrial Fibrillation Investigators (1994) Warfarin vs. aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 343:687

    Google Scholar 

  • Steinbeck G (1983) Tachykarde Rhythmusstörungen. In: Lüderitz B (Hrsg) Handbuch der inneren Medizin. Bd IX/1: Herzrhythmusstörungen. Springer, Berlin Heidelberg New York Tokyo, S 617

    Google Scholar 

  • Steinbeck G, Andresen D, Bach P et al. (1992) A comparison of electrophysiologically guided antiarrhythmic drug therapy with betablocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med 327:987

    CAS  PubMed  Google Scholar 

  • Stoddard MF et al. (1995) Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transoesophageal echocardiographic study. J Am Coll Cardiol 25:452

    CAS  PubMed  Google Scholar 

  • The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576

    Google Scholar 

  • The Cardiac Insufficiency Bisoprolol Stuby II (CIBIS-II): a randomized trial (1999) Lancet 353:9–131

    Google Scholar 

  • Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ (2002) Rate control versus electrical cardioversion for persistent atrial fibrillation study group. N Engl J Med 347:1834–1840

    PubMed  Google Scholar 

  • Vaughan-Williams EM (1970) Classification of antiarrhythmic drugs. In: Sandoe E, Flenstedt-Jensen E, Olesen KH (eds) Symposium on cardiac arrhythmias.Astra, Södertälje/Sweden, p 449

    Google Scholar 

  • Wever EF, Robles de Medina EO (2004) Sudden death in patients without structural heart disease. J Am Coll Cardiol 43:1137–1144

    Article  PubMed  Google Scholar 

Download references

Authors
  1. G. Steinbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Reithmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Näbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik und Poliklinik I und II, Klinikum der Universität München-Großhadern, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München

    Gerhard Steinbeck  & Gustav Paumgartner  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag

About this chapter

Cite this chapter

Steinbeck, G., Reithmann, C., Näbauer, M. (2005). Tachykarde Rhythmusstörungen. In: Steinbeck, G., et al. Therapie innerer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26504-X_12

Download citation

  • DOI: https://doi.org/10.1007/3-540-26504-X_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23750-1

  • Online ISBN: 978-3-540-26504-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation